MedPath

Investigating the effect of curcumin on fatty liver

Phase 3
Recruiting
Conditions
fatty liver in patients with polycystic ovary syndrome,(Only fatty liver is considered).
Fatty (change of) liver, not elsewhere classified
K76.0
Registration Number
IRCT20240215061020N1
Lead Sponsor
The University of Tarbiat Modares
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
74
Inclusion Criteria

Women of reproductive age from 18 to 45 years old
Women with polycystic ovary syndrome and non-alcoholic fatty liver disease
Having two of the three Rotterdam criteria including: having polycystic ovary ultrasound view, having serum hyperandrogenism with/without clinical symptoms related to hyperandrogenism such as acne, hirsutism, acanthosis nigricans, etc., having disordered ovulation and irregular menstrual cycle.
Being able to speak and write in Farsi

Exclusion Criteria

Pregnancy
Breastfeeding
Using hormonal methods to prevent pregnancy
Having any other diagnosed disease
Being allergic to turmeric
History of advanced chronic liver disease
Use of tobacco and alcohol
Drug addiction
Adrenal hyperplasia that has symptoms similar to polycystic ovary syndrome
Renal failure or any other active digestive disorder
Non-metabolic chronic diseases
Thyroid disease
Hyperprolactinemia

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath